Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Host-Derived Matrix Metalloproteinase-13 Activity Promotes Multiple Myeloma–Induced Osteolysis and Reduces Overall Survival
Chen Hao Lo, Gemma Shay, Jeremy McGuire, et al.
Cancer Research (2021) Vol. 81, Iss. 9, pp. 2415-2428
Open Access | Times Cited: 17

Showing 17 citing articles:

Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis
Shun Li, D. Mark Pritchard, Lu‐Gang Yu
Cancers (2022) Vol. 14, Iss. 13, pp. 3263-3263
Open Access | Times Cited: 44
Blocking glycine utilization inhibits multiple myeloma progression by disrupting glutathione balance
Jiliang Xia, Jingyu Zhang, Xuan Wu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 41
CXCL7 enhances RANKL-induced osteoclastogenesis via the activation of ERK/NFATc1 signaling pathway in inflammatory arthritis
Xinyu Wang, Lin Sun, Zhuo An, et al.
Arthritis Research & Therapy (2025) Vol. 27, Iss. 1
Open Access | Times Cited: 1
Research progress of the chemokine/chemokine receptor axes in the oncobiology of multiple myeloma (MM)
Jun Du, Lin Zheng, Xue-Hang Fu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Myeloma cell-derived CXCL7 facilitates proliferation of tumor cells and occurrence of osteolytic lesions through JAK/STAT3 pathway
Yue Wang, Tianwei Lan, Qiongyan Zhang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Matrix metalloproteinases and tissue inhibitors in multiple myeloma: promote or inhibit?
Yanying Li, Liu-Yun Zhang, Yunhui Xiang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 9
An atlas of the bone marrow bone proteome in patients with dysproteinemias
Matthew Ho, Surendra Dasari, Alissa Visram, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Redefining metalloproteases specificity through network proteolysis
Órit Kollet, Alakesh Das, Nikos K. Karamanos, et al.
Trends in Molecular Medicine (2023) Vol. 30, Iss. 2, pp. 147-163
Open Access | Times Cited: 4
Hypermethylation of the Promoter Region of miR-23 Enhances the Metastasis and Proliferation of Multiple Myeloma Cells via the Aberrant Expression of uPA
Qijie Ran, Dehong Xu, Qi Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Mmp13 deletion in mesenchymal cells increases bone mass and may attenuate the cortical bone loss caused by estrogen deficiency
Filipa Ponte, Ha‐Neui Kim, Aaron Warren, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Development of a putative Zn2+-chelating but highly selective MMP-13 inhibitor
Rita Fuerst, Jun Yong Choi, Anna M. Knapinska, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 76, pp. 129014-129014
Open Access | Times Cited: 7
Pan-cancer analysis reveals the associations between MMP13 high expression and carcinogenesis and its value as a serum diagnostic marker
Xinhui Zhang, Qingmei Deng, Xiaofeng Wan, et al.
Aging (2023) Vol. 15, Iss. 6, pp. 2115-2135
Open Access | Times Cited: 2
CXCL7 plays a crucial role in facilitating extramedullary invasion and osteolytic damage in multiple myeloma
Peng Liu, Yue J. Wang, Tianwei Lan, et al.
Research Square (Research Square) (2024)
Open Access
An atlas of the bone marrow bone proteome in patients with dysproteinemias.
Matthew Ho, Surendra Dasari, Alissa Visram, et al.
Research Square (Research Square) (2023)
Open Access
Evaluation of MMP-13 and Micro RNA-138 as prognostic biomarkers for breast cancer in Egyptian women patients
Hossam M. El‐Masry, Sally M. Khadrawy, Mahmoud M. Kamel, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155045-155045
Closed Access
Mmp13 deletion in mesenchymal cells increases bone mass and attenuates the cortical bone loss caused by estrogen deficiency
Filipa Ponte, Ha‐Neui Kim, Aaron Warren, et al.
Research Square (Research Square) (2022)
Open Access
Mmp-13 deletion in cells of the mesenchymal lineage increases bone mass, decreases endocortical osteoclast number, and attenuates the cortical bone loss caused by estrogen deficiency in mice
Filipa Ponte, Ha‐Neui Kim, Aaron Warren, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Page 1

Scroll to top